Pfizer

The Trump administration has secured a landmark agreement with pharmaceutical giant Pfizer aimed at easing the burden of prescription drug costs for low-income Americans. Under the deal, Pfizer will sell its medications to Medicaid patients at the same lowest prices offered in other wealthy countries, a shift that could significantly narrow the long-standing gap between U.S. drug costs and those abroad. 

New medicines launched by the company will also debut in the U.S. at prices matching those in other developed nations. For years, American consumers have paid more than triple the cost of brand-name drugs compared with their counterparts overseas, …